JP2021536250A5 - - Google Patents

Info

Publication number
JP2021536250A5
JP2021536250A5 JP2021512437A JP2021512437A JP2021536250A5 JP 2021536250 A5 JP2021536250 A5 JP 2021536250A5 JP 2021512437 A JP2021512437 A JP 2021512437A JP 2021512437 A JP2021512437 A JP 2021512437A JP 2021536250 A5 JP2021536250 A5 JP 2021536250A5
Authority
JP
Japan
Prior art keywords
cas9 protein
seq
motif
recombinant cas9
kferq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021512437A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021536250A (ja
JP7649735B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2019/073838 external-priority patent/WO2020049158A1/en
Publication of JP2021536250A publication Critical patent/JP2021536250A/ja
Publication of JP2021536250A5 publication Critical patent/JP2021536250A5/ja
Application granted granted Critical
Publication of JP7649735B2 publication Critical patent/JP7649735B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021512437A 2018-09-07 2019-09-06 改善されたヌクレアーゼのための組成物及び方法 Active JP7649735B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862728184P 2018-09-07 2018-09-07
US62/728,184 2018-09-07
PCT/EP2019/073838 WO2020049158A1 (en) 2018-09-07 2019-09-06 Compositions and methods for improved nucleases

Publications (3)

Publication Number Publication Date
JP2021536250A JP2021536250A (ja) 2021-12-27
JP2021536250A5 true JP2021536250A5 (cg-RX-API-DMAC7.html) 2022-09-05
JP7649735B2 JP7649735B2 (ja) 2025-03-21

Family

ID=67909383

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021512437A Active JP7649735B2 (ja) 2018-09-07 2019-09-06 改善されたヌクレアーゼのための組成物及び方法

Country Status (5)

Country Link
US (1) US12516304B2 (cg-RX-API-DMAC7.html)
EP (1) EP3847251A1 (cg-RX-API-DMAC7.html)
JP (1) JP7649735B2 (cg-RX-API-DMAC7.html)
CN (1) CN112654702B (cg-RX-API-DMAC7.html)
WO (1) WO2020049158A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019032628A1 (en) 2017-08-07 2019-02-14 The Regents Of The University Of California GENERATING PLATFORM FOR SAFE CELLULAR THERAPEUTIC AGENTS
WO2020170129A1 (en) * 2019-02-19 2020-08-27 Instituto De Biologia Experimental E Tecnológica (Ibet) A method for selective loading of proteins into exosomes and products thereof
CN115427566A (zh) * 2020-04-08 2022-12-02 阿斯利康(瑞典)有限公司 用于改善的位点特异性修饰的组合物和方法
US20250043313A1 (en) * 2021-09-13 2025-02-06 Board Of Regents, The University Of Texas System Cas9 variants with improved specificity
CN114686456B (zh) 2022-05-10 2023-02-17 中山大学 基于双分子脱氨酶互补的碱基编辑系统及其应用
CN115074387A (zh) * 2022-07-29 2022-09-20 郑州创迈生物科技有限公司 一种针对chozn细胞高效率转染的方法
US12060602B2 (en) * 2023-01-10 2024-08-13 Vedabio, Inc. Sample splitting for multiplexed detection of nucleic acids without amplification
CN118638763B (zh) * 2024-07-10 2025-03-25 北京大学 具有提高的稳定性的Cas9蛋白、试剂盒及提高Cas9蛋白稳定性的方法
CN118649229B (zh) * 2024-07-10 2025-04-22 北京大学 工程化Cas9蛋白及其制备方法和应用

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5543158A (en) 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
US6007845A (en) 1994-07-22 1999-12-28 Massachusetts Institute Of Technology Nanoparticles and microparticles of non-linear hydrophilic-hydrophobic multiblock copolymers
US5855913A (en) 1997-01-16 1999-01-05 Massachusetts Instite Of Technology Particles incorporating surfactants for pulmonary drug delivery
US5895309A (en) 1998-02-09 1999-04-20 Spector; Donald Collapsible hula-hoop
JP2008078613A (ja) 2006-08-24 2008-04-03 Rohm Co Ltd 窒化物半導体の製造方法及び窒化物半導体素子
WO2010053572A2 (en) 2008-11-07 2010-05-14 Massachusetts Institute Of Technology Aminoalcohol lipidoids and uses thereof
US8889394B2 (en) 2009-09-07 2014-11-18 Empire Technology Development Llc Multiple domain proteins
US9193827B2 (en) 2010-08-26 2015-11-24 Massachusetts Institute Of Technology Poly(beta-amino alcohols), their preparation, and uses thereof
CA2831392C (en) 2011-03-28 2020-04-28 Massachusetts Institute Of Technology Conjugated lipomers and uses thereof
US9637739B2 (en) 2012-03-20 2017-05-02 Vilnius University RNA-directed DNA cleavage by the Cas9-crRNA complex
ES2728782T3 (es) 2012-05-25 2019-10-28 Univ California Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
CN116622704A (zh) 2012-07-25 2023-08-22 布罗德研究所有限公司 可诱导的dna结合蛋白和基因组干扰工具及其应用
CA2885894C (en) 2012-09-27 2021-11-23 University Of British Columbia Peptide directed protein knockdown
CN105209621B (zh) 2012-12-12 2021-05-25 布罗德研究所有限公司 对用于序列操纵的改进的系统、方法和酶组合物进行的工程化和优化
WO2014118272A1 (en) 2013-01-30 2014-08-07 Santaris Pharma A/S Antimir-122 oligonucleotide carbohydrate conjugates
CN105408483A (zh) 2013-03-15 2016-03-16 通用医疗公司 遗传和表观遗传调节蛋白至特定基因组基因座的rna引导的靶向
US9234213B2 (en) 2013-03-15 2016-01-12 System Biosciences, Llc Compositions and methods directed to CRISPR/Cas genomic engineering systems
US20140349405A1 (en) 2013-05-22 2014-11-27 Wisconsin Alumni Research Foundation Rna-directed dna cleavage and gene editing by cas9 enzyme from neisseria meningitidis
US9322037B2 (en) 2013-09-06 2016-04-26 President And Fellows Of Harvard College Cas9-FokI fusion proteins and uses thereof
US9526784B2 (en) 2013-09-06 2016-12-27 President And Fellows Of Harvard College Delivery system for functional nucleases
WO2016021973A1 (ko) 2014-08-06 2016-02-11 주식회사 툴젠 캄필로박터 제주니 crispr/cas 시스템 유래 rgen을 이용한 유전체 교정
AU2016211517B2 (en) 2015-01-28 2021-05-13 Caribou Biosciences, Inc. CRISPR hybrid DNA/RNA polynucleotides and methods of use
US9790490B2 (en) 2015-06-18 2017-10-17 The Broad Institute Inc. CRISPR enzymes and systems
EP3929287A3 (en) * 2015-06-18 2022-04-13 The Broad Institute, Inc. Crispr enzyme mutations reducing off-target effects
WO2018068053A2 (en) * 2016-10-07 2018-04-12 Integrated Dna Technologies, Inc. S. pyogenes cas9 mutant genes and polypeptides encoded by same

Similar Documents

Publication Publication Date Title
JP4334174B2 (ja) 腫瘍崩壊性アデノウイルス
EP2447279B1 (en) Methods and compositions for gene inactivation
ES2150595T5 (es) Procedimiento de preparacion de un vector viral de por lo menos 20 kb por recombinacion homologa intermolecular en una celula procariota.
AU745560B2 (en) Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof
CN111757889A (zh) 新型CRISPR/Cas12f酶和系统
IL309801A (en) Use of protein domains interacting with the nucleosome to enhance targeted genome modification
JP2021518139A5 (cg-RX-API-DMAC7.html)
JP2021526858A5 (cg-RX-API-DMAC7.html)
KR20180012834A (ko) 두 개의 벡터로부터 발현된 Cas9 단백질을 이용한 유전자 발현 조절 방법
EP1327688A1 (en) Adenoviruses with enhanced lytic potency
JP2015533786A5 (cg-RX-API-DMAC7.html)
NO340708B1 (no) Rekombinant kimært adenovirus, replikasjonsmanglende variant derav, fremgangsmåte for isolering av adenoviruset, anvendelse derav i terapi, samt fremgangsmåte for å inhibere vekst av en kreftcelle.
JP2014516536A5 (cg-RX-API-DMAC7.html)
WO1998039467A2 (en) Adenovirus vectors specific for cells expressing carcinoembryonic antigen and methods of use thereof
JP2005515784A (ja) Podに関連した細胞活性を調節するためのアデノウイルスベクター
JP2022542294A5 (cg-RX-API-DMAC7.html)
JP2021529519A5 (cg-RX-API-DMAC7.html)
CN118649229A (zh) 工程化Cas9蛋白及其制备方法和应用
US20170183642A1 (en) Paenibacillus larvae treatment with phage lysin for american foulbrood disease
JP2002535986A (ja) 遺伝子治療用の改良ヘルパーディペンデントベクター系
JP2024501841A (ja) アデノウイルス血清型35ヘルパーベクター
Nash et al. Adenovirus Biology and Development as a Gene Delivery Vector
Hokanson et al. Hybrid yeast–bacteria cloning system used to capture and modify adenoviral and nonviral genomes
KR100808269B1 (ko) Cag 프로모터를 포함하는 아데노바이러스용 재조합 셔틀벡터
JP2014505700A (ja) 抗原性gly1ポリペプチド